GREAT — Golazo® Peripheral Atherectomy
Peripheral Artery Disease
Sponsor: Avantec Vascular · Avantec Vascular GREAT
About this study
Pivotal trial of the Golazo® peripheral atherectomy system for treatment of calcified lower-extremity arterial disease.
To evaluate the safety and effectiveness of an advanced peripheral atherectomy system for calcified lower-extremity peripheral artery disease.
Study details
- Sponsor
- Avantec Vascular
- Protocol
- Avantec Vascular GREAT
- Phase
- Pivotal
- Indication
- Peripheral Artery Disease
- Status
- Currently Recruiting
- Principal Investigator
- Pedro Martinez-Clark, MD, FACC
High-level eligibility
- Adults 18+ with symptomatic PAD
- Rutherford Class 2–4
- Suitable target lesion on imaging
Eligibility above is a summary. Final qualification is determined by the study protocol and a screening visit at amavita Heart and Vascular Health®.
I'm a sponsor / CRO →
Discuss enrollment, capacity, and operational fit.
I might be eligible — call (786) 703-5941 →
Free, no-obligation pre-screen in English / Spanish / Haitian Creole.
Participation in any clinical trial is voluntary and requires written informed consent reviewed by an Institutional Review Board (IRB) before any study procedure. You may withdraw at any time. Website content is informational and is not a substitute for medical advice from a licensed clinician.